Bruker Corporation updated earnings guidance for the fiscal year 2025. Nonetheless, due to previous market weakness and EPS dilution from higher share count, the company is lowering its financial year 2025 guidance. For the year, the company expects revenues of $3.41 to $3.44 billion, compared to fiscal 2024 revenues of $3.37 billion, with 1% to 2% year-over-year reported revenue growth including, Organic revenue decline of 4% to 5%, M&A revenue growth contribution of approximately 3.5%, Foreign currency translation revenue tailwind of approximately 2.5%.